Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
Pilot Study to Investigate the Use of Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
University of Maryland, Baltimore
30 participants
Nov 1, 2024
INTERVENTIONAL
Conditions
Summary
This study aims to evaluate the use of virtual reality as an adjunct to standard care for patients with sickle cell disease experiencing vaso-occlusive crises.
Eligibility
Inclusion Criteria3
- Adult (age > 18 years) emergency department patient
- History of sickle cell disease
- Presenting to the emergency department due to acute pain related to sickle cell disease thought to be due to vaso-occlusive crisis
Exclusion Criteria9
- Prior enrollment in this study
- Presenting with a chief complaint suggestive of a complicated crisis (such as concern for acute chest syndrome, splenic sequestration, hepatic sequestration, pulmonary embolism) as determined by the clinical care provider
- Not being treated with intravenous opioids for the vaso-occlusive crisis
- Patients who lack the capacity to provide informed consent
- Medical history of seizures or known intolerance to virtual reality
- Disabilities like vision and hearing defects etc. that preclude the use of a head mounted virtual reality device.
- Known to be pregnant
- Incarcerated at the time of evaluation
- Over the age of 89 years old
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Study Group-Virtual reality headset and hand-held controllers will be used as an adjuvant to pain management care.
Control group-Blindfold and noise cancelling headphones will be a placebo comparator group to the experimental interventions of virtual reality devices.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06184126